Archive for June, 2009

Mixed Message on Insulin Glargine Cancer Risk (CME/CE)

Tuesday, June 30th, 2009

HOUSTON (MedPage Today) — Studies examining a possible cancer link to insulin glargine (Lantus) produced mixed conclusions that drew quick, reassuring messages from diabetes authorities.

Share

‘White-Coat’ Hypertension May Persist Over Time (CME/CE)

Tuesday, June 30th, 2009

SAN FRANCISCO (MedPage Today) — Sporadic hypertension, whether just in the doctor’s office or only occasionally at home, substantially increases risk of later sustained hypertension, researchers found.

Share

Swine Flu Can Kill Even the Previously Healthy (CME/CE)

Tuesday, June 30th, 2009

LITTLE FALLS, N.J. (MedPage Today) — The new H1N1 flu virus has the ability to cause serious illness and death among young individuals with no preexisting medical conditions, Mexican researchers confirmed.

Share

ACIP: Zanamivir Best for All Flu, Including New H1N1 (CME/CE)

Tuesday, June 30th, 2009

ATLANTA (MedPage Today) — Zanamivir (Relenza) should be the preferred treatment for patients with influenza-like illness, whether infection is caused by a seasonal virus or the pandemic H1N1 virus, an advisory committee to the CDC said.

Share

ACIP: Number Infected with H1N1 Likely Tops One Million in U.S.

Tuesday, June 30th, 2009

ATLANTA (MedPage Today) — At least one million people in the U.S. have been infected with the new H1N1 flu virus, according to preliminary findings from the CDC.

Share

Mixed Message on Insulin Glargine Cancer Risk (CME/CE)

Tuesday, June 30th, 2009

HOUSTON (MedPage Today) — Studies examining a possible cancer link to insulin glargine (Lantus) produced mixed conclusions that drew quick, reassuring messages from diabetes authorities.

Share

Close Surveillance Benefits Both Early- and Late-Stage Colon Cancer (CME/CE)

Tuesday, June 30th, 2009

RIDGEWOOD, N.J. (MedPage Today) — Patients with early-stage colon cancer who develop recurrences can derive similar benefits from intensive surveillance, including increased survival, as patients with late-stage disease, a new study found.

Share

Cost of Cancer Drugs to Force Hard Decisions

Tuesday, June 30th, 2009

WHEELING, W.Va. (MedPage Today) — Studies of cancer drugs that are expected to find survival advantages of two months or less should be undertaken only if the treatment costs less than $20,000, two NIH researchers recommended.

Share

Routine Prostate Cancer Screening Not Clearly Worthwhile (CME/CE, with audio)

Tuesday, June 30th, 2009

SAN FRANCISCO (MedPage Today) — Widespread prostate cancer screening substantially increases diagnoses without much evidence for a survival benefit, a review found.

Share

‘White-Coat’ Hypertension May Persist Over Time (CME/CE)

Tuesday, June 30th, 2009

SAN FRANCISCO (MedPage Today) — Sporadic hypertension, whether just in the doctor’s office or only occasionally at home, substantially increases risk of later sustained hypertension, researchers found.

Share

brought by WordPress Themes